A pharmaceutical company in Ghana specializing in the manufacture of intravenous fluids and other pharmaceutical products.
Explore more Ghana Stock Exchange stocks, track the GSE Composite Index, read the latest GSE market news, or compare Ghana mutual funds on Wallflake.
A pharmaceutical company in Ghana specializing in the manufacture of intravenous fluids and other pharmaceutical products. Intravenous Infusions Ltd operates in the Healthcare sector and trades on the Ghana Stock Exchange under the ticker IIL.
Intravenous Infusions Ltd is listed on the Ghana Stock Exchange, where it trades under the ticker symbol IIL. It has been listed since 1969. It is classified in the Healthcare sector.
IIL last traded at GHS 0.65 on 4 September 2026, down 5.80% on the session. Live prices for Intravenous Infusions Ltd update through the trading day on Wallflake.
Intravenous Infusions Ltd has a market capitalisation of approximately GHS 243.75M, based on its closing price on 4 September 2026.
Over the past 52 weeks IIL has traded between a low of GHS 0.05 and a high of GHS 0.93.
Yes. Intravenous Infusions Ltd pays a dividend, with a trailing yield of 5.60%.
IIL shares are bought and sold through a broker licensed to trade on the Ghana Stock Exchange. You open an account with a licensed broker, fund it, and place an order quoting the ticker IIL. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our Ghana Stock Exchange guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.